By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

Other antitumor agents

Pharmaceutical group drugs

Substance Drugs
Aflibercept | | |
Aldesleukin |
Alpelisib |
Altretamine |
Amsacrine
Arsenic trioxide | |
Asparaginase | | | | | |
Bortezomib | | | | | | | | | | | | | | |
Bromebric acid
Butylated hydroxytoluene | | | | | | | |
Carfilzomib | | | | | | |
Chlorin E6 | |
Diglycidyl methylphosphonate |
Dimeglumine chlorin e6 |
Eribulin | | | | | | | |
Hydrazine sulfate |
Hydroxialuminium trisulfophtalocyanine |
Interferon alfa-2b human recombinant | | | | | | | | | | |
Lenalidomide | | | | | | | | | | | | | | | | |
Methylaminolevulinate |
Miltefosine |
Mitoxantrone | | | | | | | | |
Niraparib |
Olaparib | |
Panobinostat |
Pegaspargase |
Phenthyrin
Pomalidomide | | | | | | | | | | | |
Proxifeine | |
Quisinostat |
Selinexor |
Sonidegib |
Sotorasib |
Talazoparib |
Thioinosine
Tisagenlecleucel |
Tretinoin | | | | |
Trifluridine+Tipiracil |
Tumor necrosis factor-thymosine alpha-1 recombinant | |
Ubenimex
Venetoclax |
Vismodegib | | |
Vorinostat |
The active substance is not described Agrylin (Agrylin) | Alpharona (Alpharona) | Anagrelide (Anagrelide) | Arglabine (Arglabine) | Oncofage (Oncofage) | Phtalosens (Phtalosens) | Poglucar (Poglucar) | Radahlorin (Radahlorin) | Аналидас (Аналидас) | Мардил Селен (Мардил Селен) | Цервикон -ДИМ (Цервикон -ДИМ)

Tree of pharmacological groups

Description

There is no detailed description, see related
42a96bb5c8a2acfb07fc866444b97bf1
Available only when using PRO account
Content moderator: Vasin A. S.


  1. Kiberis is NOT an online store and does NOT purchase, store, sell or deliver drugs. The resource acts only as an intermediary between you and the manufacturer of drugs or pharmacy points, which carry out the delivery.
  2. On Kiberis there are descriptions of drugs, some of which are intended only for doctors. This information cannot be used by patients to make decisions about the use of drugs, their cancellation or correction of dosages.
  3. Nothing in the information provided should be interpreted as a call to use these drugs.
  4. No claims can be made to Kiberis regarding any damage or harm incurred as a result of the use of the information posted on the site.